Ditto Biosciences
Ditto Biosciences is a YC Winter 2026 (W26) company. Based in San Francisco, CA, USA. Team of 3.
About Ditto Biosciences
Summary
Ditto Biosciences discovers drugs for autoimmune diseases by mining proteins from parasites, viruses, ticks, and worms, organisms that have evolved over millions of years to modulate the human immune system. The team uses AI and computational protein structure prediction to identify those immunomodulatory proteins and engineer them into therapeutic candidates. This approach replaces conventional small-molecule and antibody drug discovery with biology that nature has already stress-tested across evolutionary time.
From the Y Combinator listing
Evolutionary intelligence for autoimmune disease
Ditto Bio discovers drugs for autoimmune diseases by harnessing parasite biology. Viruses, ticks, and worms have experimented over millions of years to create proteins that control the human immune system. We use AI to identify these proteins and engineer them into next-generation autoimmune therapies. Our team is three PhD scientists from UCSF, UCSD, and UC Berkeley who have worked together for 3+ years in biotech. We have deep expertise in parasite biology, computational biology, and software for AI-based protein structure prediction
Facts
- Healthcare / Healthcare -> Drug Discovery and Delivery
- San Francisco, CA, USA
- 3
- Active
- Early
Founders (3)
- Adair Borges
Score every batch against your own thesis
GPAgent's sourcing agent reads every company in a batch, scores each one against your fund's thesis in a private workspace, and lines up the founders worth meeting before Demo Day. You decide who to contact. Your scores, notes, and pipeline never appear on these pages.
How Accelerator intelligence works